Data / Form D filings / PhotonPharma, Inc.
PhotonPharma, Inc.: Form D filings
PhotonPharma, Inc., a technology company in Fort Collins, CO, filed 3 Form D notices with the SEC between 2022 and 2024. The latest, on May 22, 2024, reports $349,998 sold of a $2.5 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3185 RAMPART ROAD, D 230, Fort Collins, CO, 80521
- Phone
- (303) 887-1014
- Industry
- Other Technology
- Entity type
- Corporation
- Incorporated in
- Colorado
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1914950
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 22, 2024 | New notice | $2,500,000 | $349,998 | $2,150,002 | 2 | May 7, 2024 | sec.gov |
| Aug 29, 2023 | Amendment | $3,907,835 | $2,907,823 | $1,000,012 | 8 | Jan 31, 2022 | sec.gov |
| Mar 16, 2022 | New notice | $5,437,833 | $1,829,992 | $3,607,841 | 8 | Jan 31, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Terry Opgenorth | Director | |
| Wolfgang Baiker | Director | |
| Gary Gordon | Director | |
| Raymond Goodrich | Director | |
| Alan Rudolph | Executive Officer, Director |
Other technology companies in Colorado that filed recently
- Vescent Technologies, Inc. $16.4 million · Oct 30, 2026
- Solsis PBC $50,000 · Oct 29, 2026
- LXRE Inc. $1 million · Oct 22, 2026
- Income Laboratory, Inc. $1.3 million · Oct 21, 2026
- Moonraker Mining I, LLC $824,980 · Oct 20, 2026
- Liqid Inc. $27 million · Oct 19, 2026
Every Form D from the week of May 20, 2024 · All recent filings in Colorado · All recent Other Technology filings
Read from SEC EDGAR. Amount sold is what PhotonPharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.